Atomo
AT1.AXAtomo Diagnostics Limited Price (AT1.AX)
Stock Price
Market Cap
Fetching Data...
Enterprise Value
Fetching Data...
Volume
Fetching Data...
Shares Outstanding
634,658,764
(11.1699)%Revenue and Profitability
| Year | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 294,933 | 287,250 | 539,736 | 5,368,698 | 6,715,659 | 12,336,111 | 2,543,716 | 4,086,535 |
| Net Income | -5,148,490 | -4,900,173 | -5,055,112 | -9,218,105 | -6,021,215 | -5,706,854 | -9,957,632 | -6,847,803 |
| FCF USD | -5,861,744 | -6,202,951 | -2,651,844 | -8,255,069 | -10,122,823 | -5,112,144 | -6,248,947 | -4,702,188 |
| OCF USD | -5,255,268 | -5,560,317 | -1,838,487 | -6,261,928 | -4,225,251 | -2,806,642 | -5,847,671 | -4,686,104 |
Financial Health - DEBT
| Year | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|
| YTPD | 0.00 | -1.78 | -1.27 | 0.00 | 0.00 | -0.03 | -0.01 | 0.00 |
| D/E | 229.28 | -2.35 | -1.89 | 0.00 | 0.00 | 0.01 | 0.02 | 0.01 |
| CA/CL | 2.84 | 1.53 | 0.79 | 21.94 | 11.97 | 12.46 | 6.98 | 6.39 |
| TA/TL | 1.00 | 0.61 | 0.53 | 22.28 | 14.98 | 14.72 | 9.79 | 8.79 |
| Total Debt | 10,963,818 | 11,489,264 | 10,338,661 | 55,541 | 67,589 | 340,805 | 254,877 | 84,670 |
Management Performance
| Year | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|
| ROIC | -56.80% | -67.55% | -96.42% | -9.51% | -18.19% | -27.20% | -60.51% | -42.44% |
| ROE | -10,766.62% | 100.24% | 92.39% | -26.73% | -20.01% | -23.00% | -67.33% | -67.90% |
| ROA | 0.00% | -63.18% | -83.55% | -25.53% | -18.68% | -21.44% | -60.45% | -60.18% |
| NM % | -1,745.65% | -1,705.89% | -936.59% | -171.70% | -89.66% | -46.26% | -391.46% | -167.57% |
| FCF / R% | 0.00% | -2,159.43% | -491.32% | -153.76% | -150.73% | -41.44% | -245.66% | -115.07% |
| FCF / NI% | 113.85% | 126.59% | 52.46% | 89.55% | 168.12% | 89.58% | 62.76% | 68.67% |
| Operating Margin (OM) | 0.00 | -62.86 | -42.82 | -6.02 | -5.71 | -3.57 | -21.05 | -14.70 |
Per Share
| Year | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|
| EPS | -0.01 | -0.01 | -0.01 | -0.03 | -0.01 | -0.01 | -0.02 | -0.01 |
| SPS | 0.00 | 0.00 | 0.00 | 0.02 | 0.01 | 0.02 | 0.00 | 0.01 |
| OCPS | -0.01 | -0.01 | 0.00 | -0.02 | -0.01 | 0.00 | -0.01 | -0.01 |
| FCPS | -0.01 | -0.01 | 0.00 | -0.02 | -0.02 | -0.01 | -0.01 | -0.01 |
| BVPS | 0.00 | -0.01 | -0.01 | 0.10 | 0.05 | 0.04 | 0.03 | 0.02 |
Per Share - CAGR
| Year | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|
| CAGR-EPS | -0.01 | -0.01 | -0.01 | -0.03 | -0.01 | -0.01 | -0.02 | -0.01 |
| CAGR-SPS | 0.00 | 0.00 | 0.00 | 0.02 | 0.01 | 0.02 | 0.00 | 0.01 |
| CAGR-OCPS | -0.01 | -0.01 | 0.00 | -0.02 | -0.01 | 0.00 | -0.01 | -0.01 |
| CAGR-FCPS | -0.01 | -0.01 | 0.00 | -0.02 | -0.02 | -0.01 | -0.01 | -0.01 |
| CAGR-BVPS | 0.00 | -0.01 | -0.01 | 0.10 | 0.05 | 0.04 | 0.03 | 0.02 |